Europe — EMA
Melperon 1 A Pharma (Melperone Hydrochloride)
GNH USA supplies Melperon 1 A Pharma (Melperone), a typical antipsychotic for schizophrenia and other psychotic disorders. Request a quote for global supply.
Request sourcing
What is Melperone Hydrochloride?
Melperone, the active ingredient in Melperon 1 A Pharma, is a typical antipsychotic presented as an oral tablet for oral use. It treats schizophrenia and other psychotic disorders in adults.
GNH USA supplies Melperon 1 A Pharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Melperone Hydrochloride used for?
Melperone is a dopamine‑blocking agent used in the management of psychotic disorders. It is indicated for: - Schizophrenia: reduces hallucinations, delusions and thought disorder. - Acute psychotic episodes: helps control agitation and severe psychotic symptoms. - Maintenance therapy for chronic psychotic disorders: stabilises mood and prevents relapse.
What are the side effects of Melperone Hydrochloride?
Adverse reactions may occur with melperone therapy.
Common Side Effects: - Drowsiness - Dry mouth - Constipation - Weight gain - Orthostatic hypotension - Blurred vision
Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hypotension - Seizures - Agranulocytosis
What precautions apply to Melperone Hydrochloride?
Use melperone with careful clinical monitoring. - Blood pressure monitoring: watch for orthostatic drops. - Extrapyramidal symptom assessment: observe for tremor or rigidity. - Liver function evaluation: adjust if hepatic impairment is present. - Elderly caution: increased risk of sedation and falls. - Discontinuation: avoid abrupt cessation to prevent withdrawal effects. - Store at ambient temperature: keep in the original pack, protect from moisture.
What does Melperone Hydrochloride interact with?
Melperone can interact with several drug classes.
Major Interactions (Avoid): - CNS depressants: may enhance sedation and respiratory depression. - Antihypertensives: additive hypotensive effect. - CYP2D6 inhibitors: increase melperone plasma concentrations.
Moderate Interactions (Monitor Closely): - Antipsychotic polypharmacy: risk of cumulative side effects. - Lithium: monitor serum levels for potential toxicity.



